Fund comparison · from official SEC filings

JACCX vs JXX: how much do they overlap?

Janus Henderson Forty Fund and Janus Henderson Transformational Growth ETF
Holdings overlap
48%
of assets, by weight
Shared positions
18
of 34 / 26 holdings
JACCX expense ratio
1.64%
net, per year
JXX expense ratio
0.57%
net, per year
Shared holdings
Company
JACCX
JXX
A
AMZNAMAZON.COM INC
8.62%
11.55%
T
TSMTAIWAN SEMICONDUCTOR-SP ADR
5.50%
11.43%
A
AVGOBROADCOM INC
5.62%
8.83%
O
ORCLORACLE CORP
3.97%
6.88%
H
HWMHOWMET AEROSPACE INC
3.55%
5.13%
B
BABOEING CO/THE
1.89%
4.21%
M
MDGLMADRIGAL PHARMACEUTICALS INC
1.09%
4.13%
I
ICEINTERCONTINENTAL EXCHANGE IN
1.27%
4.09%
L
LLYELI LILLY & CO
3.62%
2.93%
D
DDOGDATADOG INC - CLASS A
2.01%
3.59%
U
UNHUNITEDHEALTH GROUP INC
1.71%
3.28%
D
DKNGDRAFTKINGS INC-CL A
2.22%
3.12%
M
MELIMERCADOLIBRE INC
2.82%
3.04%
D
DASHDOORDASH INC - A
1.36%
2.34%
C
CMGCHIPOTLE MEXICAN GRILL INC
0.91%
2.08%
D
DHRDANAHER CORP
1.82%
1.88%
P
PCVXVAXCYTE INC
0.63%
1.47%
?
Janus Henderson Cash Liquidity Fund LLC
0.19%
1.10%
Only in JACCX
N
NVDANVIDIA CORP
12.86%
M
MSFTMICROSOFT CORP
6.75%
A
AAPLAPPLE INC
5.46%
G
GOOGALPHABET INC-CL C
4.67%
E
ETNEATON CORP PLC
3.70%
M
METAMETA PLATFORMS INC-CLASS A
3.65%
G
GEVGE VERNOVA INC
2.21%
M
MAMASTERCARD INC - A
2.16%
A
ARGXARGENX SE - ADR
1.91%
B
BKNGBOOKING HOLDINGS INC
1.65%
S
SHOPSHOPIFY INC - CLASS A
1.38%
P
PLTRPALANTIR TECHNOLOGIES INC-A
1.20%
B
BXBLACKSTONE INC
1.02%
A
APPAPPLOVIN CORP-CLASS A
0.94%
L
LRCXLAM RESEARCH CORP
0.94%
M
MDLNMEDLINE INC-CL A
0.67%
Only in JXX
L
LGNLEGENCE CORP-CL A
3.78%
F
FPSFORGENT POWER SOLUTIONS-CL A
3.73%
A
AMDADVANCED MICRO DEVICES
2.81%
N
NBISNEBIUS GROUP NV
2.52%
R
RVMDREVOLUTION MEDICINES INC
2.37%
H
HOODROBINHOOD MARKETS INC - A
1.75%
?
Janus Henderson Cash Collateral Fund LLC
1.58%
R
RY 0.125 04.26.27 eMTNROYAL BANK OF CANADA
0.39%
Hold JACCX and JXX together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.